SG Americas Securities
JUNO

SG Americas Securities’s Juno Therapeutics, Inc. JUNO Stock Holding History

SG Americas Securities’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-15,377
Closed -$703K – 3738
2017
Q4 		$703K Buy
15,377
+123
+0.8% +$6.13K 0.01% 1618
2017
Q3 		$684K Buy
15,254
+1,328
+10% +$45.3K 0.01% 1564
2017
Q2 		$416K Sell
13,926
-12,763
-48% -$315K ﹤0.01% 1975
2017
Q1 		$592K Sell
26,689
-51,027
-66% -$1.09M 0.01% 1731
2016
Q4 		$1.47M Buy
77,716
+51,434
+196% +$1.26M 0.01% 1090
2016
Q3 		$789K Buy
26,282
+22,304
+561% +$694K 0.01% 1353
2016
Q2 		$153K Buy
+3,978
New +$165K ﹤0.01% 2223
2015
Q3 		– Sell
-6,214
Closed -$331K – 2941
2015
Q2 		$331K Buy
+6,214
New +$330K ﹤0.01% 1718

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

SG Americas Securities's JUNO Position: Q1 2018 in Review

SG Americas Securities sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 15,377 shares — an estimated $703K sold.

SG Americas Securities first reported a position in JUNO in Q2 2015 and held it in 8 quarters. The position peaked at $1.47M in Q4 2016. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • SG Americas Securities reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • SG Americas Securities sold 15,377 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $703K.
  • SG Americas Securities first reported a position in Juno Therapeutics, Inc. in Q2 2015 and held it in 8 quarters.
  • SG Americas Securities's Juno Therapeutics, Inc. position peaked at $1.47M in Q4 2016.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on SG Americas Securities's 13F filing for Q1 2018, filed 3 May 2018.